From the beginning to the present, birth control was always a controversial topic. Some people oppose the use of contraceptive methods and medicines around the world, others believe that this is one of the greatest inventions invented so far. In some families, associations, religions, and other countries, pre-marital abstinence or gender-free birth control is defined. Another major definition of contraceptives is the use of drugs to prevent pregnancy. Various contraceptive methods are as simple as withdrawing or withdrawing with ejaculation method.
All oral contraceptives approved by the FDA have been proven to prevent pregnancy, but some are approved as other medicines. However, the benefits of contraceptives approved as PMDD - (such as Yaz and Beyaz) were mainly evaluated by comparing them to placebo rather than other contraceptives. For PMDD it may not be more effective than more safe and cheap contraceptives. So why is not the FDA approving these other drugs for PMDD? The answer is simple: money. Yaz and other relatively new contraceptives are very expensive. Therefore, the company selling them is willing to spend extra money to apply for FDA approval of PMDD. Because older contraceptives widely used in versatile form are much cheaper, their company does not have the incentive to pay millions of dollars for FDA approval to concretely treat PMDD .
Contraceptives, including drospirenone such as YAZ and Yasmin, are being investigated by the FDA because they may increase the risk of thrombosis. Drospirenone is an artificial version of hormone progesterone. Other brands including Drospirenon include Beyaz, Safyral, Gianvi, Loryna, Ocella, Syeda and Zarah. The findings are contradictory. Several studies showed increased risk, but other studies showed no increase in risk. That medicine is still available. A summary of the findings is on the package label. If you are taking contraceptives including drospirenone, discuss the risks to your doctor.
Flickr / nateoneBack In 2008, the FDA sent a warning complaining to Bayer that two contraceptive Yaz ads seemed to divert viewers from the list of potential side effects As the narrator, the US Food and Drug Administration states that advertisements have "kaleidoscopes with fast tempo" including songs of women and chats with friends. Indeed, she said that she often saw deliberately dull ads and lazy and discreet stories set for "slowly swelling stringed instruments". "It will make you very calm," Faber said. However, this does not necessarily mean that consumers can better absorb this information, rather than using changing narratives.